Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI CURE: Naltrexone in Opioid Dependence
NCT01587196Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2012
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jan 2012; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01587196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01587196.